C Campagnoli

2.4k total citations · 1 hit paper
58 papers, 1.8k citations indexed

About

C Campagnoli is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, C Campagnoli has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 35 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Oncology. Recurrent topics in C Campagnoli's work include Estrogen and related hormone effects (34 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Menopause: Health Impacts and Treatments (16 papers). C Campagnoli is often cited by papers focused on Estrogen and related hormone effects (34 papers), Growth Hormone and Insulin-like Growth Factors (16 papers) and Menopause: Health Impacts and Treatments (16 papers). C Campagnoli collaborates with scholars based in Italy, Germany and Austria. C Campagnoli's co-authors include Jörge R. Pasqualini, René Druckmann, Karl-Werner Schweppe, Johannes Huber, Jos H.H. Thijssen, Adolf E. Schindler, Clementina Peris, Nicoletta Biglia, P Sismondi and Franco Berrino and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and American Journal of Obstetrics and Gynecology.

In The Last Decade

C Campagnoli

57 papers receiving 1.6k citations

Hit Papers

Classification and pharmacology of progestins 2003 2026 2010 2018 2003 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Campagnoli Italy 22 697 667 383 377 370 58 1.8k
Clare D. Edman United States 18 478 0.7× 638 1.0× 218 0.6× 374 1.0× 231 0.6× 22 1.4k
José‐Luis Gomez Canada 24 1.4k 2.0× 621 0.9× 367 1.0× 453 1.2× 244 0.7× 27 2.9k
Ko-En Huang Taiwan 18 495 0.7× 463 0.7× 151 0.4× 473 1.3× 261 0.7× 22 1.6k
Léonello Cusan Canada 30 1.7k 2.5× 859 1.3× 286 0.7× 593 1.6× 257 0.7× 42 3.2k
D. M. Hart United Kingdom 22 835 1.2× 586 0.9× 192 0.5× 202 0.5× 192 0.5× 70 1.6k
Charlene Franz United States 15 455 0.7× 445 0.7× 308 0.8× 185 0.5× 221 0.6× 18 1.2k
T. Rabe Germany 24 440 0.6× 351 0.5× 98 0.3× 642 1.7× 592 1.6× 141 1.9k
J. Spona Austria 21 217 0.3× 247 0.4× 313 0.8× 413 1.1× 316 0.9× 127 1.5k
John L. Kirkland United States 26 568 0.8× 710 1.1× 127 0.3× 280 0.7× 144 0.4× 76 2.0k
Graeme R. Frank United States 16 1.0k 1.5× 1.4k 2.1× 376 1.0× 728 1.9× 292 0.8× 35 3.0k

Countries citing papers authored by C Campagnoli

Since Specialization
Citations

This map shows the geographic impact of C Campagnoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Campagnoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Campagnoli more than expected).

Fields of papers citing papers by C Campagnoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Campagnoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Campagnoli. The network helps show where C Campagnoli may publish in the future.

Co-authorship network of co-authors of C Campagnoli

This figure shows the co-authorship network connecting the top 25 collaborators of C Campagnoli. A scholar is included among the top collaborators of C Campagnoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Campagnoli. C Campagnoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pulito, Claudio, Federica Mori, Andrea Sacconi, et al.. (2017). Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities. Cell Discovery. 3(1). 17022–17022. 67 indexed citations
2.
Campagnoli, C, Franco Berrino, Elisabetta Venturelli, et al.. (2013). Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer. Clinical Breast Cancer. 13(6). 433–438. 48 indexed citations
3.
Campagnoli, C, et al.. (2013). Postmenopausal breast cancer, androgens, and aromatase inhibitors. Breast Cancer Research and Treatment. 139(1). 1–11. 27 indexed citations
4.
Campagnoli, C, et al.. (2009). Progestogen use in women approaching the menopause and breast cancer risk. Maturitas. 62(4). 338–342. 6 indexed citations
5.
Campagnoli, C, et al.. (2007). Differential effects of various progestogens on metabolic risk factors for breast cancer. Gynecological Endocrinology. 23(sup1). 22–31. 3 indexed citations
6.
Campagnoli, C, et al.. (2005). Pregnancy, progesterone and progestins in relation to breast cancer risk. The Journal of Steroid Biochemistry and Molecular Biology. 97(5). 441–450. 31 indexed citations
8.
Schindler, Adolf E., C Campagnoli, René Druckmann, et al.. (2003). Classification and pharmacology of progestins. Maturitas. 46. 7–16. 516 indexed citations breakdown →
9.
Campagnoli, C, et al.. (2003). Differential effects of progestins on the circulating IGF-I system. Maturitas. 46. 39–44. 25 indexed citations
10.
Campagnoli, C, Paola Colombo, Domenico De Aloysio, et al.. (2002). Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. Maturitas. 41(4). 299–311. 24 indexed citations
11.
Campagnoli, C, et al.. (2001). Breast cancer and hormone replacement therapy: putting the risk into perspective. Gynecological Endocrinology. 15(sup6). 53–60. 6 indexed citations
12.
Meschìa, Michele, F. Pansini, Alberto Bacchi Modena, et al.. (2000). Determinants of age at menopause in Italy: results from a large cross-sectional study. Maturitas. 34(2). 119–125. 76 indexed citations
13.
Adámi, S., Vincenzina Bruni, Angelamaria Becorpi, et al.. (2000). Prevention of early postmenopausal bone loss with cyclical etidronate. Journal of Endocrinological Investigation. 23(5). 310–316. 13 indexed citations
14.
Huber, J., C Campagnoli, René Druckmann, et al.. (1999). Recommendations for estrogen and progestin replacement in the climacteric and postmenopause. Maturitas. 33(3). 197–209. 6 indexed citations
15.
Campagnoli, C, et al.. (1999). HRT and breast cancer risk: a clue for interpreting the available data. Maturitas. 33(3). 185–190. 15 indexed citations
17.
Bacchi-Modena, Alberto, et al.. (1997). Efficacy and tolerability of ®estraderm MX, a new estradiol matrix patch. Maturitas. 27(3). 285–292. 22 indexed citations
20.
Isaia, Giancarlo, et al.. (1989). Calcitonin and lumbar bone mineral content during oestrogen-progestogen administration in post-menopausal women. Maturitas. 11(4). 287–294. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026